BM4SIT is a health project supported by the European Union
Latest News
  • This page is not being updated since 11th August, 2020. For updates and latest news please visit this site.


Homepage Maintenance

The page is not being updated since 11th August, 2020. For updates and latest news visit this site.


Introduction & General Terms

BM4SIT - "An innovative causal therapy for allergy: safe and rapid induction of an antiinflammatory immune response using a mutant hypoallergen and Vitamin D3" is a collaborative project supported by the European Commission under the 7th Framework Programme for Research, technological Developement and Demonstration (proposal number: 601763-2).

Project Coordinator: Prof. Dr. Ronald van Ree

Media owner, publisher, content and editorial responsibility for the pages with the domain

Paris-Lodron-University of Salzburg
Kapitelgasse 4
5020 Salzburg
Telephone: +43 (0) 662-8044-0
Fax: +43 (0) 662-8044-145

Prof. Dr. Fátima Ferreira
University of Salzburg
Department of Molecular Biology
Hellbrunnerstr. 34
5020 Salzburg
Contact: fatima.ferreira(at)

UID-Nr: ATU57532824

Technical Implementation:
University of Salzburg
Department: IT-Service
Contact: webmaster(at)


The texts on the website have been reviewed carefully before publication. Nevertheless, we can not guarantee the accuracy, completeness or timeliness of the information. A liability of the University of Salzburg is excluded. The links to other pages have been carefully selected. The University of Salzburg is not responsible for the content of linked websites.


The World Wide Web content is for online access. Copyright and terms of use for text, graphics, design, source code belong to the University of Salzburg. The Copyright for images belongs to fotolia ( The production, use and non-commercial dissemination of copies in electronic or printed form are permitted if the content remains unaltered and if references are mentioned (Source: University of Salzburg).